- Home
- UG vs AEON Comparison
UG vs AEON Comparison
Compare UG & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UG | AEON |
|---|---|---|
| Founded | 1942 | N/A |
| Country | United States | United States |
| Employees | N/A | 5 |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.2M | 26.8M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | UG | AEON |
|---|---|---|
| Price | $6.70 | $0.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.20 |
| AVG Volume (30 Days) | 3.4K | ★ 65.8K |
| Earning Date | 03-27-2026 | 03-30-2026 |
| Dividend Yield | ★ 7.53% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $10,545,468.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $33.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.58 | $0.38 |
| 52 Week High | $9.88 | $1.45 |
Technical Indicators
Market Signals| Indicator | UG | AEON |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 42.54 |
| Support Level | $6.26 | $0.94 |
| Resistance Level | $6.78 | $1.12 |
| Average True Range (ATR) | 0.19 | 0.13 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 78.21 | 6.77 |
Price Performance
Historical ComparisonAbout UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.